BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 6457173)

  • 1. [Bacteriological and clinical studies of 6059-S in pediatric infections (author's transl)].
    Terashima I; Nakamura A; Okimoto U; Sugaya N; Kurosaki T; Sato T; Iwata Y; Saito N; Uehara S
    Jpn J Antibiot; 1981 May; 34(5):747-56. PubMed ID: 6457173
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical study on 6059-S in children (author's transl)].
    Yanagisawa K; Ide K; Hoshina H; Ichihashi H
    Jpn J Antibiot; 1981 May; 34(5):757-63. PubMed ID: 6457174
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical studies on 6059-S in pediatric field (author's transl)].
    Nagata K; Fujita M; Haneda S; Aoyama R; Izumi Y
    Jpn J Antibiot; 1981 Apr; 34(4):558-61. PubMed ID: 6457164
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical studies of 6059-S in the field of pediatrics (author's transl)].
    Minamitani M; Hachimori K; Tomori N
    Jpn J Antibiot; 1981 Apr; 34(4):608-17. PubMed ID: 6457169
    [No Abstract]   [Full Text] [Related]  

  • 5. [Haemophilus influenzae type b meningitis resistant to ampicillin and chloramphenicol treated with moxalactam].
    Gómez-Acebo F; Palenque E; Scarpellini Vera A; Rodríguez Otero JJ; Fernández Epifanio JL
    An Esp Pediatr; 1983 May; 18(5):410-1. PubMed ID: 6225361
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical evaluation of 6059-S in children, particularly in the treatment of bacterial meningitis (author's transl)].
    Kobayashi Y; Haruta T; Kuroki S; Okura K; Fujiwara T; Morikawa Y
    Jpn J Antibiot; 1981 Apr; 34(4):587-98. PubMed ID: 6457167
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies of moxalactam for gram-negative and Haemophilus influenzae meningitis: an appraisal.
    Dillon HC
    J Pediatr; 1981 Dec; 99(6):907-8. PubMed ID: 6458672
    [No Abstract]   [Full Text] [Related]  

  • 8. [Fundamental and clinical studies on CS-1170 (author's transl)].
    Motohiro T; Sakata Y; Nishiyama T; Ishimoto K; Tominaga K; Yamashita F
    Jpn J Antibiot; 1979 Feb; 32(2):195-204. PubMed ID: 439391
    [No Abstract]   [Full Text] [Related]  

  • 9. [Laboratory and clinical studies on 6059-S in children (author's transl)].
    Iwai N; Sasaki A; Taneda Y; Osuga T; Inokuma K
    Jpn J Antibiot; 1981 May; 34(5):782-99. PubMed ID: 6457176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moxalactam treatment of serious infections primarily due to Haemophilus influenzae type b in children.
    Kaplan SL; Mason EO; Kvernland SJ; Loiselle EM; Feigin RD
    Pediatrics; 1983 Feb; 71(2):187-91. PubMed ID: 6218472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Moxalactam in the treatment of pediatric infections.
    Yogev R; Schreiber M; Gardner S; Shulman ST
    Am J Dis Child; 1982 Sep; 136(9):836-9. PubMed ID: 6214182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Fundamental and clinical studies of CS-1170 in children (author's transl)].
    Kobayashi Y; Morikawa Y; Haruta T; Fujiwara T; Yamamoto I; Nanba I; Okuhara K; Kanaoka T; Yamagami M; Mochizuki Y; Ono Y; Teramura F; Shinomiya K
    Jpn J Antibiot; 1979 Jan; 32(1):41-59. PubMed ID: 423366
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of experimental Haemophilus influenzae type b meningitis with 1-oxa-beta-lactam (LY127935).
    Cordera CS; Pekarek RS
    Antimicrob Agents Chemother; 1980 Feb; 17(2):258-62. PubMed ID: 6446260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fundamental and clinical studies of T-1982 (cefbuperazone) in the pediatric field].
    Motohiro T; Koga T; Tomita N; Fujimoto T; Nishiyama T; Ishimoto K; Tominaga K; Yamashita F; Koga Y; Takajo N; Araki H; Tanaka K; Imai S; Yuasa T; Nagayama K; Tsugawa S; Tanaka Y; Shimada Y; Aramaki S; Iriki T; Cho H; Yamamoto M; Komatsu Y; Tanaka C; Yuge K; Toyoda A; Matsunaga S; Yukizane S; Takechi T; Matsuo H; Eto Y; Matsuyuki M
    Jpn J Antibiot; 1983 Apr; 36(4):888-909. PubMed ID: 6348343
    [No Abstract]   [Full Text] [Related]  

  • 15. [Laboratory and clinical studies of T-1982 (cefbuperazone) in pediatrics].
    Sekiguchi T; Ichioka T; Hosoda T; Masuda M; Miyao M
    Jpn J Antibiot; 1983 Apr; 36(4):869-76. PubMed ID: 6348341
    [No Abstract]   [Full Text] [Related]  

  • 16. [Evaluation of CS-1170 in pediatric field (author's transl)].
    Iwai N; Sasaki A; Futamura J; Miyatsu M; Osuga T
    Jpn J Antibiot; 1979 Feb; 32(2):205-20. PubMed ID: 439392
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical effectiveness of CS-1170 in the pediatric field (author's transl)].
    Minamitani M; Hachimori K; Tomori N
    Jpn J Antibiot; 1979 Feb; 32(2):241-6. PubMed ID: 439396
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical evaluation of CS-1170 in pediatric field (author's transl)].
    Sawai M; Fujii R
    Jpn J Antibiot; 1979 Feb; 32(2):247-52. PubMed ID: 439397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ampicillin resistance in Haemophilus influenzae--test methods for the activity of acylureidopenicillins, cephamycins and new cephalosporins.
    Newsom SW; Matthews J
    J Antimicrob Chemother; 1982 Dec; 10(6):527-32. PubMed ID: 6984444
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical experience with T-1982 (cefbuperazone) in the pediatric field].
    Miyauchi Y; Nishimori M; Asano E; Sakaguchi Z; Ohara K; Okamoto T
    Jpn J Antibiot; 1983 Apr; 36(4):855-61. PubMed ID: 6348340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.